We conducted the first clinical trial with the novel PlasmaDerm VU-2010 device to assess safety and , as secondary endpoints , efficacy and applicability of 45 s/cm ( 2 ) cold atmospheric plasma as add-on therapy against chronic venous leg ulcers .